as on February 6, 2026 at 2:28 am IST
Day's Low
Day's High
0.83%
Downside
5.13%
Upside
52 Week's Low
52 Week's High
38.70%
Downside
31.76%
Upside
Check Kalvista Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$753.6M
EPS (TTM)
-4.06
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-14.79
Industry PE ratio
-1.8111934156378602
PEG Ratio
0EBITDA
-201.8M
Revenue (TTM)
1.4M
Profit Margin
0.00%
Return On Equity TTM
-190.18%
Track how Kalvista Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Kalvista Pharmaceuticals Inc in the last 5 years
Lowest (-10.90x)
April 30, 2021
Today (-14.79x)
February 5, 2026
Industry (-1.81x)
February 5, 2026
Highest (-1.43x)
October 31, 2022
Today’s Price to Earnings Ratio: -14.79x
Compare market cap, revenue, PE, and other key metrics of Kalvista Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $753.6M | -1.51% | -14.79 | 0.00% | |
| BUY | $122.3B | 118.58% | 33.56 | 31.35% | |
| BUY | $47.7B | 113.17% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 55.33% | 18.28 | 32.13% |
The Kalvista Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kalvista Pharmaceuticals Inc investment value today
Current value as on today
₹1,49,025
Returns
₹49,025
(+49.02%)
Returns from Kalvista Pharmaceuticals Inc Stock
₹45,657 (+45.66%)
Dollar Returns*
₹3,368 (+3.37%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Kalvista Pharmaceuticals Inc. Average target price of $33.78
Get share price movements and forecasts by analysts on Kalvista Pharmaceuticals Inc.
What analysts predicted
57.31%UPSIDE
Target Price
$33.78
Current Price
$14.42
Analyzed by
12 Analysts
Target
$33.78
Kalvista Pharmaceuticals Inc target price $33.78, a slight upside of 57.31% compared to current price of $14.42. According to 12 analysts rating.
Search interest for Kalvista Pharmaceuticals Inc Stock has increased by 87% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:87% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 12 September
Fri, 06:16 PM
-Analyst Andrew Fein maintains Buy rating on KalVista, citing strong early launch metrics for Ekterly and a price target of $27.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, KALV stock has moved up by 36.3%
Best in 3 Years
![]()
In the last 3 years, KALV has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 54.6% return, outperforming this stock by 3.3%
| Organisation | Kalvista Pharmaceuticals Inc |
| Headquarters | 200 Crossing Boulevard, Framingham, MA, United States, 01702 |
| Industry | Health Technology |
| CEO | Mr. Benjamin L. Palleiko |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Linea Aspesi | Chief People Officer |
Mr. Benjamin L. Palleiko | CEO & Director |
Dr. Paul K. Audhya M.B.A., M.D. | Chief Medical Officer |
Mr. Ryan Baker | Head of Investor Relations |
Mr. Brian Krex J.D. | General Counsel |
Jarrod Aldom | Vice President of Corporate Communications |
Ms. Rachel M. Morten | Senior Vice President of Regulatory Affairs & QA |
Dr. Christopher M. Yea Ph.D. | Chief Development Officer |
Mr. Brian Piekos | Chief Financial Officer |
Mr. Bilal Arif | Chief Operating Officer |
Kalvista Pharmaceuticals Inc share price today is $14.42 as on at the close of the market. Kalvista Pharmaceuticals Inc share today touched a day high of $15.16 and a low of $14.3.
Kalvista Pharmaceuticals Inc share touched a 52 week high of $19 on and a 52 week low of $8.84 on . Kalvista Pharmaceuticals Inc stock price today i.e. is closed at $14.42,which is 24.11% down from its 52 week high and 63.12% up from its 52 week low.
Kalvista Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Kalvista Pharmaceuticals Inc (KALV) shares with as little as ₹90.283 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.83 in Kalvista Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kalvista Pharmaceuticals Inc share’s latest price of $14.42 as on February 6, 2026 at 2:28 am IST, you will get 0.6935 shares of Kalvista Pharmaceuticals Inc. Learn more about
fractional shares .
Kalvista Pharmaceuticals Inc stock has given -1.51% share price returns and 25.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?